Main Outcome Measures: We measured FC before and after completion of the CRP and the improvement expressed in percents of FC before the CRP.
The modeled SWC (optimized with the CRP measurements) within the CRP footprint was relatively close to the CRP-measured SWC with a RMSE of 0.047 cm3 cm33.
Different concentrations of the CRP were coated onto the electrode with respect to anti-CRP antibodies.
The CRP found no trouble raising campaign funds.
Dark money spending rose from just under $6m in 2006 to $131m in 2010 following the decision, according to the CRP.
Different people produce different amounts of CRP, and the amount a person produces is determined by tiny inherited changes in the CRP gene.
To suggest that the CRP is a screening test for heart disease, as some now do, invites undue medical bills and costly interventions.
The CRP levels were not related to target vessel revascularization.
The CRP mean values significantly differed between groups.
Results: FC in both patient groups improved after the CRP.
In group 1 patients, FC increased from 5.6±2.3 metabolic equivalents (METS) before the CRP to 7.5±2.6 METS after the CRP (P<.01).
